{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T22:17:46Z","timestamp":1774563466004,"version":"3.50.1"},"reference-count":26,"publisher":"Wiley","issue":"s2","license":[{"start":{"date-parts":[[2002,2,21]],"date-time":"2002-02-21T00:00:00Z","timestamp":1014249600000},"content-version":"vor","delay-in-days":82,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Transplant Infectious Dis"],"published-print":{"date-parts":[[2001,12]]},"abstract":"<jats:p>Cytomegalovirus (CMV) infection and disease continue to be significant causes of morbidity and mortality in lung transplant recipients. The potential benefits of CMV prophylaxis extend beyond prevention of the immediate CMV infection to potentially preventing CMV\u2010associated complications, including superinfection due to <jats:italic>Aspergillus<\/jats:italic> bacteria, and other opportunistic infections, and bronchiolitis obliterans syndrome (BOS). Longer courses of prophylactic intravenous (IV) ganciclovir, sequential IV\/oral therapy, addition of intravenous CMV immune globulin (CMV\u2010IGIV), surveillance tests, and investigation of the role of hypogammaglobulinemia are a few of the strategies and issues being evaluated to improve CMV prophylaxis and, consequently, graft and patient survival.<\/jats:p>","DOI":"10.1034\/j.1399-3062.2001.00010.x","type":"journal-article","created":{"date-parts":[[2003,3,12]],"date-time":"2003-03-12T21:26:23Z","timestamp":1047504383000},"page":"49-56","source":"Crossref","is-referenced-by-count":26,"title":["Use of cytomegalovirus immune globulin and ganciclovir for the prevention of cytomegalovirus disease in lung transplantation"],"prefix":"10.1111","volume":"3","author":[{"given":"M.R.","family":"Zamora","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2002,2,21]]},"reference":[{"key":"e_1_2_8_2_2","first-page":"7","article-title":"Advances in understanding cytomegalovirus infection after transplantation","volume":"26","author":"Ho M","year":"1994","journal-title":"Transplant Proc"},{"key":"e_1_2_8_3_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-199306000-00013"},{"key":"e_1_2_8_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0928-0197(98)00040-3"},{"key":"e_1_2_8_5_2","doi-asserted-by":"publisher","DOI":"10.1136\/thx.50.1.9"},{"key":"e_1_2_8_6_2","doi-asserted-by":"publisher","DOI":"10.1159\/000029481"},{"key":"e_1_2_8_7_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-200107150-00027"},{"key":"e_1_2_8_8_2","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1128\/JCM.38.2.768-772.2000","article-title":"Comparison of PCR, antigenemia assay and rapid blood culture for detection and prevention of cytomegalovirus disease after lung transplantation","volume":"38","author":"Weinberg A","year":"2000","journal-title":"J Clin Microbiol"},{"key":"e_1_2_8_9_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-200106150-00021"},{"key":"e_1_2_8_10_2","first-page":"12","article-title":"Evaluation of the AMPLICOR CMV, COBAS AMPLICOR CMV monitor, and antigenemia assay for cytomegalovirus disease","volume":"54","author":"Masaoka T","year":"2001","journal-title":"Jpn J Infect Dis"},{"key":"e_1_2_8_11_2","first-page":"913","article-title":"Randomized trial of daily versus three\u2010times\u2010weekly prophylactic ganciclovir after lung and heart\u2010lung transplantation","volume":"17","author":"Hertz MI","year":"1998","journal-title":"J Heart Lung Transplant"},{"key":"e_1_2_8_12_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/165.3.548"},{"key":"e_1_2_8_13_2","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm\/146.6.1419"},{"key":"e_1_2_8_14_2","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm.150.1.8025741"},{"key":"e_1_2_8_15_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-199504270-00012"},{"key":"e_1_2_8_16_2","first-page":"881","article-title":"Impact of ganciclovir prophylaxis on heart\u2010lung and lung transplant recipients","volume":"15","author":"Soghikian MV","year":"1996","journal-title":"J Heart Lung Transplant"},{"key":"e_1_2_8_17_2","first-page":"49","article-title":"Prevention and treatment of cytomegalovirus disease in thoracic organ transplant patients: evidence for a beneficial effect of hyperimmune globulin","volume":"27","author":"Valantine HA","year":"1995","journal-title":"Transplant Proc"},{"key":"e_1_2_8_18_2","first-page":"49","article-title":"Use of Cytomegalovirus hyperimmune globulin for the prevention of CMV disease in CMV seropositive lung transplant recipients","volume":"26","author":"Zamora MR","year":"1994","journal-title":"Transplant Proc"},{"key":"e_1_2_8_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1053-2498(99)80201-0"},{"key":"e_1_2_8_20_2","first-page":"96.","article-title":"Comparison between CMV hyperimmune globulin and GCV for CMV prophylaxis in heart\u2010lung and lung transplant recipients","volume":"17","author":"Poirier CD","year":"1998","journal-title":"J Heart Lung Transplant"},{"key":"e_1_2_8_21_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-199803150-00026"},{"key":"e_1_2_8_22_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-200004271-00108"},{"key":"e_1_2_8_23_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-199911150-00010"},{"key":"e_1_2_8_24_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-198906000-00007"},{"key":"e_1_2_8_25_2","doi-asserted-by":"publisher","DOI":"10.1034\/j.1399-3046.2001.00026.x"},{"key":"e_1_2_8_26_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-200101270-00013"},{"key":"e_1_2_8_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1053-2498(00)00426-5"}],"container-title":["Transplant Infectious Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1034%2Fj.1399-3062.2001.00010.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1034%2Fj.1399-3062.2001.00010.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1034\/j.1399-3062.2001.00010.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,27]],"date-time":"2023-09-27T13:10:40Z","timestamp":1695820240000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1034\/j.1399-3062.2001.00010.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,12]]},"references-count":26,"journal-issue":{"issue":"s2","published-print":{"date-parts":[[2001,12]]}},"alternative-id":["10.1034\/j.1399-3062.2001.00010.x"],"URL":"https:\/\/doi.org\/10.1034\/j.1399-3062.2001.00010.x","archive":["Portico"],"relation":{},"ISSN":["1398-2273","1399-3062"],"issn-type":[{"value":"1398-2273","type":"print"},{"value":"1399-3062","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,12]]}}}